XML 60 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Parent
Common Stock
Capital in Excess of Par Value
Cumulative Net Income
Cumulative Distributions
Non-controlling Interests
Total
Balance at beginning of period at Dec. 31, 2016 $ 740,048 $ 392 $ 839,005 $ 1,013,443 $ (1,112,792)   $ 740,048
Balance (in shares) at Dec. 31, 2016   39,221          
Equity activity              
Common stock cash distributions (90,219)       (90,219)   (90,219)
Issuance of common stock 14,529 $ 3 14,526       14,529
Issuance of common stock (in shares)   313          
Issuance of restricted stock (20) $ 1 (21)       (20)
Issuance of restricted stock (in shares)   85          
Stock option exercises 202   202       202
Stock option exercises (in shares)   8          
Stock-based compensation expense 5,247   5,247       5,247
Net income 87,340     87,340     87,340
Non-controlling interests contributions           $ 3,488 3,488
Other (1,969)   (1,969)       (1,969)
Other (in shares)   (57)          
Vested stock options 2   2       2
Balance at end of period at Dec. 31, 2017 755,160 $ 396 856,992 1,100,783 (1,203,011) 3,488 758,648
Balance (in shares) at Dec. 31, 2017   39,570          
Equity activity              
Common stock cash distributions (90,372)       (90,372)   (90,372)
Issuance of common stock 929   929       929
Issuance of common stock (in shares)   22          
Issuance of restricted stock (8) $ 1 (9)       (8)
Issuance of restricted stock (in shares)   91          
Stock option exercises 123   123       123
Stock option exercises (in shares)   5          
Stock-based compensation expense 5,870   5,870       5,870
Net income 154,981     154,981   95 155,076
Non-controlling interests contributions           3,963 3,963
Non-controlling interest distributions           (65) (65)
Other (1,193)   (1,193)       (1,193)
Other (in shares)   (31)          
Balance at end of period at Dec. 31, 2018 825,490 $ 397 862,712 1,255,764 (1,293,383) 7,481 832,971
Balance (in shares) at Dec. 31, 2018   39,657          
Equity activity              
As Adjusted Balance at January 1, 2019 782,682 $ 397 862,712 1,212,956 (1,293,383) 7,481 790,163
Net income             80,872
Vesting of performance-based stock units (301)       (301)   (301)
Vesting of performance-based stock units   48          
Balance at end of period at Dec. 31, 2019 776,943 $ 398 867,346 1,293,482 (1,384,283) 8,483 785,426
Balance (in shares) at Dec. 31, 2019   39,752          
Equity activity              
Cumulative effect of the adoption of the ASC 842 (42,808)     (42,808)     (42,808)
Common stock cash distributions (90,599)       (90,599)   (90,599)
Issuance of restricted stock (7)   (7)       (7)
Issuance of restricted stock (in shares)   86          
Stock option exercises 123 $ 1 122       123
Stock option exercises (in shares)   5          
Stock-based compensation expense 6,566   6,566       6,566
Net income 80,526     80,526   346 80,872
Non-controlling interests contributions           965 965
Non-controlling interest distributions           (309) (309)
Other (2,047)   (2,047)       (2,047)
Other (in shares)   (44)          
Balance at end of period at Dec. 31, 2019 $ 776,943 $ 398 $ 867,346 $ 1,293,482 $ (1,384,283) $ 8,483 $ 785,426
Balance (in shares) at Dec. 31, 2019   39,752